5 resultat
BACKGROUND OF THE INVENTION
Field of the Invention
The present disclosure is directed to novel aliphatic prolinamide derivatives, pharmaceutical compositions containing such novel compounds, as well as methods for preventing and treating age-related macular degeneration (AMD) and related diseases of
BACKGROUND OF THE INVENTION
Field of the Invention
The present disclosure is directed to novel carbocyclic prolinamide derivatives, pharmaceutical compositions containing such novel compounds, as well as methods for preventing and treating age-related macular degeneration (AMD) and related diseases
TECHNICAL FIELD
The present invention relates to an angiogenesis inhibitor comprising a cysteine protease inhibitory compound.
BACKGROUND OF THE INVENTION
An angiogenesis is a phenomenon wherein new blood vessels are created to form a new vascular network in the living body. The angiogenesis is
TECHNICAL FIELD
The present invention relates to an angiogenesis inhibitor comprising a cysteine protease inhibitory compound.
BACKGROUND OF THE INVENTION
An angiogenesis is a phenomenon wherein new blood vessels are created to form a new vascular network in the living body. The angiogenesis is
TECHNICAL FIELD
The present invention relates to an angiogenesis inhibitor comprising a cysteine protease inhibitory compound.
BACKGROUND OF THE INVENTION
An angiogenesis is a phenomenon wherein new blood vessels are created to form a new vascular network in the living body. The angiogenesis is